IRBM strongly believes in creating value through alliances for co-development and for drug discovery projects on partner’s equity. Thus we provide drug discovery and development services to big-pharma, not for profit and academic institutions adopting a flexible business model that can be modulated according to needs.
We dedicate an interdisciplinary project team to progress a partner project from early stage (screening or hit phase) to preclinical development operating on a FTE-based approach. The team will be assembled with a Senior Project Leader and an enthusiastic team of drug hunters with a proven track record at delivering solutions and progressing effectively to the milestone.
We are also happy to address specific tasks on a fee-for-service base or adopting a risk-sharing R&D contract agreement sharing costs and linking downstream payments to agreed milestones.